Serhat Emeksiz

Serhat Emeksiz

Auto-generated profile, based on publicly available information

Serhat Emeksiz

Division of Pediatric Intensive Care, Department of Pediatrics, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2021 in Pediatric Cardiology
Verified
Journal Article
Open access
PDF file
AKAhmet Vedat Kavurt
Ahmet Vedat Kavurt
DBDenizhan Bağrul
Denizhan Bağrul
AGAyşe Esin Kibar Gül
Ayşe Esin Kibar Gül
NÖNevin Özdemiroğlu
Nevin Özdemiroğlu
IEİbRahim Ece
İbRahim Ece
BGBelgin Gülhan
Belgin Gülhan
Cardiac involvement is a common and serious problem in multisystem inflammatory syndrome in children (MIS-C). Echocardiographic evaluation of systolic and diastolic function by traditional, tissue Doppler and three-dimensional (3D) echocardiography was performed in consecutive 50 MIS-C patients during hospitalization and age-matched 40 healthy controls. On the day of worst left ventricular (LV) systolic function (echo-1), all left and right ventricular systolic function parameters were significantly lower (p < 0.001), E/A ratio was significantly lower, and averaged E/e′ ratio was significantly higher (median 1.5 vs. 1.8, p < 0.05; 8.9 vs. 6.3, p < 0.001 respectively) in patients compared to control. Patients were divided into 2 groups according to 3D LV ejection fraction (LVEF) on the echo-1: Group 1; LVEF < 55%, 26 patients, and group 2; LVEF ≥ 55%, 24 patients. E/e′ ratio was significantly higher in group 1 than group 2 and control at discharge (median 7.4 vs. 6.9, p = 0.005; 7.4 vs. 6.3, p < 0.001 respectively). Coronary ectasia was detected in 2 patients (z score: 2.53, 2.6 in the right coronary artery), and resolved at discharge. Compared with group 2, group 1 had significantly higher troponin-I (median 658 vs. 65 ng/L; p < 0.001), NT-pro BNP (median 14,233 vs. 1824 ng/L; p = 0.001), procalcitonin (median 10.9 vs. 2.1 µg/L; p = 0.009), ferritin (median 1234 vs. 308 µg/L; p = 0.003). The most common findings were ventricular systolic dysfunction recovering during hospitalization, and persisting LV diastolic dysfunction in the reduced LVEF group at discharge. Coronary artery involvement was rare in the acute phase of the disease. Also, in MIS-C patients, the correlation between LV systolic dysfunction and markers of inflammation and cardiac biomarkers should be considered.

9 June 2021 in International Journal Of Clinical Practice
Verified
Journal Article
Open access
PDF file
SESerhat Emeksiz
Serhat Emeksiz
BABanu Çelikel Acar
Banu Çelikel Acar
AKAyşe Esin Kibar
Ayşe Esin Kibar
APAslınur Özkaya Parlakay
Aslınur Özkaya Parlakay
OPOktay Perk
Oktay Perk
EŞEmrah Şenel
Emrah Şenel
Objective Although the initial reports of COVID-19 cases in children described that children were largely protected from severe manifestations, clusters of paediatric cases of severe systemic hyperinflammation and shock related to severe acute respiratory syndrome coronavirus 2 infection began to be reported in the latter half of April 2020. A novel syndrome called “multisystem inflammatory syndrome in children” (MIS-C) shares common clinical features with other well-defined syndromes, including Kawasaki disease, toxic shock syndrome and secondary hemophagocytic lymphohistiocytosis/macrophage activation syndrome. Our objective was to develop a protocol for the evaluation, treatment and follow-up of patients with MIS-C. Methods The protocol was developed by a multidisciplinary team. We convened a multidisciplinary working group with representation from the departments of paediatric critical care, cardiology, rheumatology, surgery, gastroenterology, haematology, immunology, infectious disease and neurology. Our protocol and recommendations were based on the literature and our experiences with multisystem inflammatory syndrome in children. After an agreement was reached and the protocol was implemented, revisions were made on the basis of expert feedback. Conclusion Children may experience acute cardiac decompensation or other organ system failure due to this severe inflammatory condition. Therefore, patients with severe symptoms of MIS-C should be managed in a paediatric intensive care setting, as rapid clinical deterioration may occur. Therapeutic approaches for MIS-C should be tailored depending on the patients’ phenotypes. Plasmapheresis may be useful as a standard treatment to control hypercytokinemia in cases of MIS-C with severe symptoms. Long-term follow-up of patients with cardiac involvement is required to identify any sequelae of MIS-C.

1 June 2021 in Transfusion and Apheresis Science
Verified
Journal Article
Closed access
SESerhat Emeksiz
Serhat Emeksiz
SÖSerhan Özcan
Serhan Özcan
OPOktay Perk
Oktay Perk
EUEmel Uyar
Emel Uyar
BABanu Çelikel Acar
Banu Çelikel Acar
EŞEmrah Şenel
Emrah Şenel

26 December 2016 in Turkish Archives of Pediatrics
Verified
Journal Article
Closed access
SESerhat Emeksiz
Serhat Emeksiz
NKNurettin Onur Kutlu
Nurettin Onur Kutlu
HCHuseyin Caksen
Huseyin Caksen
GAGulsum Alkan
Gulsum Alkan
HYHulya Seker Yikmaz
Hulya Seker Yikmaz
HTHuseyin Tokgoz
Huseyin Tokgoz
Posterior reversible encephalopathy syndrome is characterized by hypertension, seizure, headache, clouding of consciousness, and visual disturbance, and is diagnosed in the presence of typical lesions on magnetic resonance imaging. We retrospectively evaluated five patients who were diagnosed as having posterior reversible encephalopathy syndrome and followed up in Meram Medical Faculty, Pediatric Intensive Care and Hematology wards, between January 2010 and January 2014. We reviewed the demographic and clinical data, and neuroimaging findings. The primary diseases of the subjects included acute lymphocytic leukemia (n=2), Henoch-Schönlein purpura (n=1), systemic lupus erythematous (n=1), and acute poststreptococcal glomerulonephritis (n=1). The mean age was 10±4.58 years (range, 5-14 years). Acute elevation of blood pressure was found in all patients (n=5). Initial neurologic manifestations included seizure, clouding of consciousness, headache, and visual disturbance. After the diagnosis was made through clinical evaluations and magnetic resonance imaging, complete clinical recovery was obtained in all patients with the appropriate therapeutic approach. In conclusion, posterior reversible encephalopathy syndrome should be considered in the differential diagnosis of patients who present with encephalopathy and underlying diseases such as nephritis, vasculitis, malignancy accompanied by hypertension, and a history of use of medication.

30 September 2021 in Environmental Science and Pollution Research
Verified
Journal Article
Closed access
PDF file
GAGanime Ayar
Ganime Ayar
SYSıddika Songül Yalçın
Sıddika Songül Yalçın
AYAnıl Yirün
Anıl Yirün
SESerhat Emeksiz
Serhat Emeksiz
ABAylin Balcı
Aylin Balcı
PEPinar Erkekoglu
Pinar Erkekoglu

1 December 2021 in Journal of Tropical Pediatrics
Verified
Journal Article
Open access
PDF file
OPOktay Perk
Oktay Perk
SOSerhan Ozcan
Serhan Ozcan
SESerhat Emeksiz
Serhat Emeksiz
EUEmel Uyar
Emel Uyar
BGBelgin Gulhan
Belgin Gulhan
COVID-19 originated in Wuhan, China, at the end of 2019 and has since spread around the world. During the key period of the pandemic from 1 March 2020, to 1 March 2021, the pediatric intensive care unit registered a total of 72 patients testing positive for SARS-CoV-2 and 130 patients positive for RVP on the respiratory virus panel. In this single-center study, we compared the clinical differences and course of the disease in pediatric intensive care patients infected with SARS-CoV-2 with patients diagnosed with respiratory tract viruses during the COVID-19 outbreak. Unlike previous studies, this is the first to compare the clinical manifestations of COVID-19 with other respiratory pathogens requiring intensive care. Respiratory support therapy, such as high-flow nasal cannula (HFNC) and NIV, was prescribed more frequently in RVP patients than in COVID-19 patients. In our study, low oxygen saturation in the arterial blood (SaO2), increased OSI and increased fraction of inspired oxygen (FiO2) requirements were more significant in RVP patients than in COVID-19 patients. In parallel, the need for mechanical ventilation was higher in RVP patients than in COVID-19 patients. Therefore, we believe that RVP patients should be followed more carefully during this pandemic period.